help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ramkumar, V.
Right arrow Articles by Stiles, G. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ramkumar, V.
Right arrow Articles by Stiles, G. L.

Endocrinology, Vol 126, 1295-1304, Copyright © 1990 by Endocrine Society


ARTICLES

In vivo pertussis toxin administration: effects on the function and levels of Gi alpha proteins and their messenger ribonucleic acids

V Ramkumar and GL Stiles
Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710.

Pertussis toxin ADP-ribosylates and functionally inactivates a number of guanine nucleotide-binding proteins (G-proteins), including the inhibitory G-protein, Gi. Once ADP-ribosylated, the subsequent duration of inactivation and fate of these proteins in cells are unknown. In the present study, therefore, we have attempted to answer some of these questions in an in vivo rat adipocyte model. Our results indicate a rather prolonged (greater than 2 weeks) inactivation of Gi, as evidenced by loss of R-phenylisopropyladenosine-mediated inhibition of adenylate cyclase activity in rat adipocyte membranes after administration of the toxin in vivo. This was associated with a complete loss of pertussis toxin ADP-ribosylatable substrates on days 3 and 15, with only partial recovery by day 28 after initiation of treatment. Specific antibodies used to quantitate the levels of alpha i1- and alpha 12-subunits of alpha i indicate a 2-fold increase in the levels of these proteins by day 3, followed by a progressive decrease and subsequent recovery in these subunits to 53%, 47%, and 87% of the control value on days 15, 20, and 28, respectively. No change in the levels of alpha s was observed at all time points tested. The levels of mRNA encoding the alpha i proteins were measured using specific oligonucleotide probes to determine whether changes in the levels of these transcripts could explain the observed regulation of alpha i. At the early time point (day 3), there was no alteration in the mRNA for alpha 3, alpha i1, alpha i2, and alpha i3 in fat pads from control and treated rats. However, the levels of the alpha i1 transcript decreased slightly in the treated groups on day 15-20 by a maximum of 33% and partially recovered by day 28. No changes in the alpha i2, alpha i3, alpha s, or tubulin transcripts were observed over the same treatment period. These results provide the first evidence that ADP ribosylation of the alpha i proteins by pertussis toxin leads to significant alterations in their levels. Furthermore, alterations in the levels of alpha i proteins (except alpha i1) do not appear to result from transcriptional regulation.


This article has been cited by other articles:


Home page
HypertensionHome page
T. Shimosawa, K. Ando, and T. Fujita
A Newly Identified Peptide, Proadrenomedullin N-Terminal 20 Peptide, Induces Hypotensive Action via Pertussis Toxin–Sensitive Mechanisms
Hypertension, November 1, 1997; 30(5): 1009 - 1014.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1990 by The Endocrine Society